(196 days)
Not Found
No
The device description and performance studies focus on the physical components and the ability of the medium to preserve bacterial viability, with no mention of AI or ML.
No.
The device is used for collecting and transporting specimens for diagnostic purposes, not for treating a disease or medical condition.
No
This device is a collection and transport system intended to preserve the viability of enteric bacteria during transport to a testing laboratory for examination and culture. It does not perform any diagnostic function itself.
No
The device description clearly outlines physical components: a sterile peel pouch, a rayon tipped swab applicator, and a polypropylene tube containing Cary-Blair medium. This indicates a hardware-based medical device, not software-only.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states it's for the "collection and transport of clinical fecal and rectal swab specimens to preserve the viability of enteric bacteria during transport from the collection site to the testing laboratory for bacteriological examination and culture." This clearly indicates the device is used in vitro (outside the body) to prepare a specimen for subsequent diagnostic testing in a laboratory.
- Device Description: The description details a system for collecting and transporting a biological specimen (fecal and rectal swabs) using a medium designed to maintain the viability of microorganisms for laboratory analysis.
- Performance Studies: The performance studies focus on "Recovery Testing" and "Stability Testing" related to the ability of the system to maintain the viability of bacteria for "bacteriological examination and culture." These are all activities performed in a laboratory setting for diagnostic purposes.
- Predicate Device: The predicate device listed (Copan Venturi Transystem Cary-Blair Medium product) is also a collection and transport system for specimens intended for laboratory testing, which are typically classified as IVDs.
The device is designed to be used in vitro to prepare a specimen for a diagnostic test (bacteriological examination and culture) performed in a laboratory. This aligns directly with the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Puritan Opti-Tranz Cary-Blair Collection and Transport System is intended for use in the collection and transport of clinical fecal and rectal swab specimens to preserve the viability of enteric bacteria during transport from the collection site to the testing laboratory for bacteriological examination and culture.
Product codes (comma separated list FDA assigned to the subject device)
JSM, LIO, JTW
Device Description
Puritan Opti-Tranz Cary-Blair Collection and Transport System is comprised of a sterile peel pouch containing a rayon tipped swab applicator for collecting specimens and a polypropylene tube containing 5 ml of Cary-Blair medium.
Cary-Blair medium is a nonnutritive balanced salt solution containing disodium phosphate to provide buffering capability, sodium chloride and calcium chloride to provide essential ions that help maintain osmotic balance. Agar is a solidifying agent and gives a semisolid texture to the medium. Sodium thioglycollate provides a reduced environment. It is recommended for maintaining the viability of enteric bacteria during the transport to the laboratory.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
clinical fecal and rectal swab specimens
Indicated Patient Age Range
Not Found
Intended User / Care Setting
collection site to the testing laboratory
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Recovery Testing: To determine the ability of the Puritan Opti-Tranz Cary-Blair Collection and Transport System to maintain viability of different strains of enteric bacteria, known inoculum of clinically significant ATCC type culture microorganisms were inoculated into the Puritan Opti-Tranz Cary-Blair Collection and Transport medium and compared to the predicate device following Clinical and Laboratory Standards Institute (CLSI) M40-A2 guidelines. No notable differences in recovery were detected between the Puritan Opti-Tranz Cary-Blair Collection and Transport System and the predicate device. Recovery was also evaluated using three representative challenge organisms to demonstrate that the performance of the Puritan Opti-Tranz Cary-Blair Collection and Transport medium is not adversely affected by fecal material. It was determined that clinical fecal material does not notably alter the recovery of the challenge organisms from the Puritan Opti-Tranz Cary-Blair Collection and Transport System.
Stability Testing: Stability tests were performed on Puritan Opti-Tranz Cary-Blair Collection and Transport System to verify the ability of the aged products to maintain microbial recovery up to the expiry date.
pH Stability: The pH of the test device was measured at predetermined time intervals for up to 20 months after manufacturing date. The test was performed using calibrated pH meter with random samples from three different lots of Puritan Opti-Tranz Cary-Blair Collection and Transport System. All samples tested were found to maintain pH within the specified range.
Cytotoxicity: Cytotoxicity testing was conducted to evaluate the glue, shaft and the rayon tipped swabs for potential cytotoxicity effect following ISO Elution Method-1X MEM Extract. No evidence of cytotoxicity was detected.
Sterilization: Puritan Opti-Tranz Cary-Blair Collection and Transport System is sterilized by gamma irradiation and validated following ANSI/AAMI/ISO 11137:2006, Sterilization of health care products Radiation guidelines.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 866.2390 Transport culture medium.
(a)
Identification. A transport culture medium is a device that consists of a semisolid, usually non-nutrient, medium that maintains the viability of suspected pathogens contained in patient specimens while in transit from the specimen collection area to the laboratory. The device aids in the diagnosis of disease caused by pathogenic microorganisms and also provides epidemiological information on these diseases.(b)
Classification. Class I (general controls).
0
Image /page/0/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized image of three human profiles facing to the right, with flowing lines beneath them.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 29, 2016
PURITAN MEDICAL PRODUCTS LLC MEHDI KARAMCHI VICE PRESIDENT OF SCIENTIFIC AFFAIRS 31 SCHOOL STREET P.O. BOX 149 GUILFORD ME 04443-0149
Re: K160082
Trade/Device Name: Puritan Opti-Tranz Cary-Blair Collection and Transport System Regulation Number: 21 CFR 866,2390 Regulation Name: Transport culture medium Regulatory Class: I Product Code: JSM, LIO, JTW Dated: July 14, 2016 Received: July 18, 2016
Dear Mr. Karamchi:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Ribhi Shawar -S
Uwe Scherf, M.Sc., Ph.D. For Director Division of Microbiology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K160082
Device Name
Puritan Opti-Tranz Cary-Blair Collection and Transport System
Indications for Use (Describe)
Puritan Opti-Tranz Cary-Blair Collection and Transport System is in the collection and transport of clinical fecal and rectal swab specimens to preserve the viability of enteria during transport from the collection site to the testing laboratory for bacteriological examination and culture.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
Puritan® Opti-Tranz™ Cary-Blair Collection and Transport System
5.1 Sponsor
Puritan Medical Products LLC
31 School St., Guilford, ME
04443
| Contact: | Mehdi Karamchi |
|---|---|
| ---------- | ---------------- |
| Telephone Number: | 207-876-3311 |
|---|---|
| Fax Number: | 207-876-2680 |
Date: May 25, 2016
5.2 Device Name
| Classification Name: | Transport Culture Medium |
|---|---|
| Common Name: | Specimen Collection and Transport System |
| Proprietary Name: | Puritan® Opti-Tranz™ Cary-Blair Collection and Transport System |
5.3 Regulatory Information
| A. Regulatory Section: | 21 CFR 866.2390 |
|---|---|
| ------------------------ | ----------------- |
- B. Classification: Class I
- C. Product Code: LIO, JSM, JTW
- D. Panel: Microbiology (83)
5.4 Predicate Device
Copan Venturi Transystem Cary-Blair Medium product (132C)
510K Number: K946286
4
5.5 Device Description
Puritan Opti-Tranz Cary-Blair Collection and Transport System is comprised of a sterile peel pouch containing a rayon tipped swab applicator for collecting specimens and a polypropylene tube containing 5 ml of Cary-Blair medium.
Cary-Blair medium is a nonnutritive balanced salt solution containing disodium phosphate to provide buffering capability, sodium chloride and calcium chloride to provide essential ions that help maintain osmotic balance. Agar is a solidifying agent and gives a semisolid texture to the medium. Sodium thioglycollate provides a reduced environment. It is recommended for maintaining the viability of enteric bacteria during the transport to the laboratory.
5.6 Intended Use
Puritan Opti-Tranz Cary-Blair Collection and Transport System is intended for use in the collection and transport of clinical fecal and rectal swab specimens to preserve the viability of enteric bacteria during transport from the collection site to the testing laboratory for bacteriological examination and culture.
5.7 Indication(s) For Use
Puritan Opti-Tranz Cary-Blair Collection and Transport System is intended for use in the collection and transport of clinical fecal and rectal swab specimens to preserve the viability of enteric bacteria during transport from the collection site to the testing laboratory for bacteriological examination and culture.
Substantial Equivalence statement 5.8.
Puritan Opti-Tranz Cary-Blair Collection and Transport System is similar in design, manufacturing and intended usage to the predicate device. Both the Puritan and the predicate device are single-use devices intended for collection and transport of clinical specimens containing enteric bacteria from the patient site to the testing laboratory for bacteriological examination and culture.
5
| Puritan and Predicate Device Comparision | ||
|---|---|---|
| Item | Puritan Test Device | Predicate |
| Intended USE | Puritan Opti-Tranz Cary-Blair | |
| Collection and Transport | ||
| System is a sterile ready-to- use | ||
| system intended for collection | ||
| and transport of clinical fecal | ||
| and rectal swab specimens to | ||
| preserve the viability of enteric | ||
| bacteria during transport from | ||
| the collection site to the testing | ||
| laboratory for bacteriological | ||
| examination and culture. | Copan Venturi Transystem | |
| Cary-Blair Medium product | ||
| (132C) is a sterile ready-to-use | ||
| system intended for the safe | ||
| collection, transport, and | ||
| preservation of clinical | ||
| specimens for bacteriological | ||
| examination. Product 132C is | ||
| supplied with a plastic | ||
| applicator swab. The Venturi | ||
| Transystem with Cary-Blair | ||
| Transport Medium is | ||
| recommended for the | ||
| collection and transport of | ||
| fecal and rectal swab samples | ||
| for the investigation of enteric | ||
| pathogenic bacteria. | ||
| Single-use Device | Yes | Same |
| Medium Formulation | Sodium chloride | |
| Disodium phosphate | ||
| Sodium thioglycollate | ||
| Calcium chloride | ||
| Agar | ||
| Water | Same | |
| pH | 6.90-7.50 | $8.4 ± 0.2$ |
| Storage Temperature | 2-25°C (refrigerated and room | |
| temperature) | Same | |
| Container | Plastic round bottom tube | Same |
| Product Configuration | Medium in tubes & Plug | |
| System including Medium and | Same |
6
| swab in peel pouch option. | ||
|---|---|---|
| Swab Shaft | Plastic | Same |
| Swab Tip | Rayon tipped swab | Same |
| Shelf Life | 20 months | 24 months |
5.9 Recovery Testing
To determine the ability of the Puritan Opti-Tranz Cary-Blair Collection and Transport System to maintain viability of different strains of enteric bacteria, known inoculum of clinically significant ATCC type culture microorganisms were inoculated into the Puritan Opti-Tranz Cary-Blair Collection and Transport medium and compared to the predicate device following Clinical and Laboratory Standards Institute (CLSI) M40-A2 guidelines. No notable differences in recovery were detected between the Puritan Opti-Tranz Cary-Blair Collection and Transport System and the predicate device.
Recovery was also evaluated using three representative challenge organisms to demonstrate that the performance of the Puritan Opti-Tranz Cary-Blair Collection and Transport medium is not adversely affected by fecal material. It was determined that clinical fecal material does not notably alter the recovery of the challenge organisms from the Puritan Opti-Tranz Cary-Blair Collection and Transport System.
5.10 Stability Testing
Stability tests were performed on Puritan Opti-Tranz Cary-Blair Collection and Transport System to verify the ability of the aged products to maintain microbial recovery up to the expiry date.
5.11 pH Stability
The pH of the test device was measured at predetermined time intervals for up to 20 months after manufacturing date. The test was performed using calibrated pH meter with random samples from three different lots of Puritan Opti-Tranz Cary-Blair Collection and Transport System. All samples tested were found to maintain pH within the specified range.
5.12 Cytotoxicity
Cytotoxicity testing was conducted to evaluate the glue, shaft and the rayon tipped swabs for potential cytotoxicity effect following ISO Elution Method-1X MEM Extract. No evidence of cytotoxicity was detected.
7
5.13 Sterilization
Puritan Opti-Tranz Cary-Blair Collection and Transport System is sterilized by gamma irradiation and validated following ANSI/AAMI/ISO 11137:2006, Sterilization of health care products Radiation guidelines.
5.14 Conclusion
The conclusions drawn from the nonclinical tests demonstrate the device is as safe and effective as the legally marketed device identified above.